Bevacizumab (Avastin) for the treatment of ocular disease.

The use of intravitreal bevacizumab (Avastin) has greatly expanded since its introduction into ophthalmic care 3 years ago. A PubMed search on 1 August 2008 revealed 51 ocular disease processes that have been treated with bevacizumab. The majority of publications consist of case reports or retrospective case series and their number is increasing quickly.

Optical coherence tomography findings in central retinal artery occlusion.

This article describes optical coherence tomography (OCT) findings in patients with central retinal artery occlusion by conducting a retrospective review of two cases. Central retinal artery occlusion shows a distinct pattern on OCT images. In the acute phase, OCT images demonstrate the increased reflectivity and thickness of the inner retina and a corresponding decrease of reflectivity in the outer layer of the retina and retinal pigment epithelium/choriocapillaris layer.